URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Timothy Stevens

TitleAssociate Professor
InstitutionSchool of Medicine and Dentistry
DepartmentPediatrics
AddressUniversity of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 651
Rochester NY 14642
 
 Awards And Honors
1991     National Defense Service Medal
1991     Air Force Training Ribbon
1991     Air Force Outstanding Unit Award
1995     Appointed to NIH Molecular Biology Training Grant, University of Rochester, Rochester, NY
1998     Excellence in Teaching Award Family Practice Residency Program, St. Joseph's Hospital, Syracuse NY
2000     Excellence in Teaching Award, Family Practice Residency Program, St. Joseph's Hospital, Syracuse NY
2008     University of Rochester Medical Center Board Excellence Award
2010     Health Care Achievement Award for Innovation Rochester Business Journal
2012     Ruth A. Lawrence Faculty Service Award for Clinical Services
 
 Overview
Dr. Stevens' primary research interest centers on pulmonary outcome of premature infants, especially the neonatal antecedents of later lung dysfunction that cause infants to require ongoing pulmonary care in childhood. Areas of clinical research include:

1) Supplemental oxygen exposure, oxidant stress and risk of later wheezing in formerly premature infants. Investigative methods include meta-analysis of existing clinical research data, retrospective analysis of existing data sets as well as prospective clinical studies. Two prospective clinical research projects, a randomized clinical trial and a prospective cohort study, are underway to study the effect of supplemental oxygen exposure on risk of wheezing in later childhood. The overarching hypothesis of the prospective trials is that premature infants exposed to supplemental oxygen in the immediate newborn period experience oxidant stress in the lung that results in impaired airway growth and development. These airway changes predispose premature infants to greater airway dysfunction and respiratory symptoms when challenged with subsequent environmental or infectious exposures.

2) Risk of RSV-related hospitalization of formerly premature infants

3) Use of surfactant replacement therapy in the treatment of RDS

4) Outcome of infants with Congenital Diaphragmatic Hernia

 
 Selected Publications
List All   |   Timeline
  1. Carroll KN, Griffin MR, Edwards KM, Ali A, Zhu Y, Iwane MK, Szilagyi PG, Staat MA, Stevens TP, Hall CB, Williams JV, Hartert TV. Adherence to guidelines for respiratory syncytial virus immunoprophylaxis among infants with prematurity or chronic lung disease in three United States counties. Pediatr Infect Dis J. 2012 Nov; 31(11):e229-31.
    View in: PubMed
  2. Stevens TP, Schulman J. Evidence-based approach to preventing central line-associated bloodstream infection in the NICU. Acta Paediatr Suppl. 2012 Apr; 101(464):11-6.
    View in: PubMed
  3. Butler-O'Hara M, D'Angio CT, Hoey H, Stevens TP. An evidence-based catheter bundle alters central venous catheter strategy in newborn infants. J Pediatr. 2012 Jun; 160(6):972-7.e2.
    View in: PubMed
  4. Schulman J, Stricof R, Stevens TP, Horgan M, Gase K, Holzman IR, Koppel RI, Nafday S, Gibbs K, Angert R, Simmonds A, Furdon SA, Saiman L. Statewide NICU central-line-associated bloodstream infection rates decline after bundles and checklists. Pediatrics. 2011 Mar; 127(3):436-44.
    View in: PubMed
  5. Ellsworth MA, Stevens TP, D'Angio CT. Infant race affects application of clinical guidelines when screening for drugs of abuse in newborns. Pediatrics. 2010 Jun; 125(6):e1379-85.
    View in: PubMed
  6. Stevens TP, Dylag A, Panthagani I, Pryhuber G, Halterman J. Effect of cumulative oxygen exposure on respiratory symptoms during infancy among VLBW infants without bronchopulmonary dysplasia. Pediatr Pulmonol. 2010 Apr; 45(4):371-9.
    View in: PubMed
  7. Schulman J, Stricof RL, Stevens TP, Holzman IR, Shields EP, Angert RM, Wasserman-Hoff RS, Nafday SM, Saiman L. Development of a statewide collaborative to decrease NICU central line-associated bloodstream infections. J Perinatol. 2009 Sep; 29(9):591-9.
    View in: PubMed
  8. Stevens TP, van Wijngaarden E, Ackerman KG, Lally PA, Lally KP. Timing of delivery and survival rates for infants with prenatal diagnoses of congenital diaphragmatic hernia. Pediatrics. 2009 Feb; 123(2):494-502.
    View in: PubMed
  9. Narang S, Roy J, Stevens TP, Butler-O'Hara M, Mullen CA, D'Angio CT. Risk factors for umbilical venous catheter-associated thrombosis in very low birth weight infants. Pediatr Blood Cancer. 2009 Jan; 52(1):75-9.
    View in: PubMed
  10. Halterman JS, Lynch KA, Conn KM, Hernandez TE, Perry TT, Stevens TP. Environmental exposures and respiratory morbidity among very low birth weight infants at 1 year of life. Arch Dis Child. 2009 Jan; 94(1):28-32.
    View in: PubMed
  11. Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev. 2007; (4):CD003063.
    View in: PubMed
  12. Stevens TP, Sinkin RA. Surfactant replacement therapy. Chest. 2007 May; 131(5):1577-82.
    View in: PubMed
  13. Elhassan NO, Sorbero ME, Hall CB, Stevens TP, Dick AW. Cost-effectiveness analysis of palivizumab in premature infants without chronic lung disease. Arch Pediatr Adolesc Med. 2006 Oct; 160(10):1070-6.
    View in: PubMed
  14. Aris C, Stevens TP, Lemura C, Lipke B, McMullen S, Côté-Arsenault D, Consenstein L. NICU nurses' knowledge and discharge teaching related to infant sleep position and risk of SIDS. Adv Neonatal Care. 2006 Oct; 6(5):281-94.
    View in: PubMed
  15. Reininger A, Khalak R, Kendig JW, Ryan RM, Stevens TP, Reubens L, D'Angio CT. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial. J Perinatol. 2005 Nov; 25(11):703-8.
    View in: PubMed
  16. Stevens TP, Hall CB. Controversies in palivizumab use. Pediatr Infect Dis J. 2004 Nov; 23(11):1051-2.
    View in: PubMed
  17. Edwards WH, Conner JM, Soll RF. The effect of prophylactic ointment therapy on nosocomial sepsis rates and skin integrity in infants with birth weights of 501 to 1000 g. Pediatrics. 2004 May; 113(5):1195-203.
    View in: PubMed
  18. Elhassan NO, Stevens TP, Gigliotti F, Hardy DJ, Cole CA, Sinkin RA. Vancomycin usage in central venous catheters in a neonatal intensive care unit. Pediatr Infect Dis J. 2004 Mar; 23(3):201-6.
    View in: PubMed
  19. Stevens TP, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev. 2004; (3):CD003063.
    View in: PubMed
  20. Elhassan NO, Stevens TP, Sorbero ME, Dick AW, Guillet R, Hall CB. Guidelines for palivizumab prophylaxis: are they based on infant's risk of hospitalization for respiratory syncytial viral disease? Pediatr Infect Dis J. 2003 Nov; 22(11):939-43.
    View in: PubMed
  21. D'Angio CT, Sinkin RA, Stevens TP, Landfish NK, Merzbach JL, Ryan RM, Phelps DL, Palumbo DR, Myers GJ. Longitudinal, 15-year follow-up of children born at less than 29 weeks' gestation after introduction of surfactant therapy into a region: neurologic, cognitive, and educational outcomes. Pediatrics. 2002 Dec; 110(6):1094-102.
    View in: PubMed
  22. Stevens TP, Chess PR, McConnochie KM, Sinkin RA, Guillet R, Maniscalco WM, Fisher SG. Survival in early- and late-term infants with congenital diaphragmatic hernia treated with extracorporeal membrane oxygenation. Pediatrics. 2002 Sep; 110(3):590-6.
    View in: PubMed
  23. Stevens TP, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS. Cochrane Database Syst Rev. 2002; (2):CD003063.
    View in: PubMed
  24. Stevens TP, Sinkin RA, Hall CB, Maniscalco WM, McConnochie KM. Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis. Arch Pediatr Adolesc Med. 2000 Jan; 154(1):55-61.
    View in: PubMed
  25. Hall CB, Stevens TP, Swantz RJ, Sinkin RA, McBride JT. Development of local guidelines for prevention of respiratory syncytial viral infections. Pediatr Infect Dis J. 1999 Oct; 18(10):850-3.
    View in: PubMed
  26. Watson WJ, Stevens TP, Weinberg GA. Profound anemia in a newborn infant of a mother receiving antiretroviral therapy. Pediatr Infect Dis J. 1998 May; 17(5):435-6.
    View in: PubMed
  27. Stevens TP, McBride JT, Peake JL, Pinkerton KE, Stripp BR. Cell proliferation contributes to PNEC hyperplasia after acute airway injury. Am J Physiol. 1997 Mar; 272(3 Pt 1):L486-93.
    View in: PubMed
  28. Stevens TP, Guillet R. Use of glucagon to treat neonatal low-output congestive heart failure after maternal labetalol therapy. J Pediatr. 1995 Jul; 127(1):151-3.
    View in: PubMed

Visualizations


Stevens's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department